IGC Pharma Inc IGC

Healthcare Cannabis

IGC Pharma, Inc. is a clinical-stage company, which is engaged in developing treatments for Alzheimer’s disease. The Company’s flagship drug, IGC-AD1, is an investigational drug tackles agitation, a major burden for patients and caregivers by addressing neuroinflammation. The Company operates through two segments: Life Sciences Segment and Infrastructure Segment. Its TGR-63 has demonstrated its potential to disrupt the progression of Alzheimer’s by targeting Aß plaques, a key disease hallmark. The Company’s IGC-1C represents a potential breakthrough by targeting tau protein and neurofibrillary tangles, aiming to modify the disease course. Its IGC-M3 focuses on early intervention by inhibiting Aß plaque formation, potentially slowing cognitive decline. Its LMP is designed to target multiple hallmarks of Alzheimer’s disease, including Aß plaques and neurofibrillary tangles for a comprehensive therapeutic effect. It seeks to leverage artificial intelligence (AI) for Alzheimer's research.

NYSEAM:IGC - Post by User

IGC Pharma Inc

Bullboard Posts

Post by GoldMineeon Oct 01, 2018 11:10am

167 Views

Post# 28721400

Crop Infrastructure

This stock has been flying! Must be because of the CBD space. Next biggest producer expanding so much right now in US and Europe is $CROP.

Take the gains over there as it will be the next flyer.

Bullboard Posts

Options trading in a volatile macro environment